We are live on ! Find out more
MSAC

Medicus Sciences Acquisition Corp. Class A Ordinary Share

Delisted

MSAC was delisted on the 17th of February, 2023.

46 hedge funds and large institutions have $77.5M invested in Medicus Sciences Acquisition Corp. Class A Ordinary Share in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 5

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

9% more capital invested

Capital invested by funds: $71.4M → $77.5M (+$6.11M)

5% more funds holding

Funds holding: 4446 (+2)

Holders
46
Holders Change
+2
Holders Change %
+4.55%
% of All Funds
0.81%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
5
Increased
12
Reduced
5
Closed
3
Calls
$38K
Puts
Net Calls
+$38K
Net Calls Change
-$12K
Name Holding Trade Value Shares
Change
Change in
Stake
PCM
26
Pentwater Capital Management
Florida
$488K
RCM
27
Rivernorth Capital Management
Florida
$488K
AGM
28
Alpine Global Management
New York
$488K +$67K +6,950 +16%
FTCM
29
Fir Tree Capital Management
New York
$449K
HighTower Advisors
30
HighTower Advisors
Illinois
$397K
SSA
31
Schonfeld Strategic Advisors
New York
$390K +$193K +20,000 +100%
RCM
32
Robinson Capital Management
Michigan
$306K +$303K +31,412 New
HF
33
HRT Financial
New York
$272K -$2.58K -268 -1%
Verition Fund Management
34
Verition Fund Management
Connecticut
$244K
MP
35
Mangrove Partners
Connecticut
$237K -$709K -73,640 -75%
LC
36
Littlejohn & Co
Connecticut
$195K
Goldman Sachs
37
Goldman Sachs
New York
$166K +$963 +100 +0.6%
GCIA
38
Gabelli & Co Investment Advisers
New York
$150K
GF
39
Gabelli Funds
New York
$142K
E
40
Ergoteles
New York
$132K
RCM
41
Radcliffe Capital Management
Pennsylvania
$116K
WAM
42
Wolverine Asset Management
Illinois
$107K +$58.7K +6,094 +124%
MIG
43
Mariner Investment Group
New York
$98K +$96.3K +10,000 New
AA
44
Ancora Advisors
Ohio
$35K +$20.2K +2,100 +140%
CCM
45
Condor Capital Management
New Jersey
$27K +$19.3K +2,000 +263%
CIM
46
Cowen Investment Management
New York
$1.71K +$963K +100,000 +133%
JGC
47
J. Goldman & Co
New York
-$2.89M -300,000 Closed
OFG
48
OTA Financial Group
New York
-$209K -21,728 Closed
OMC
49
Old Mission Capital
Illinois
-$139K -14,362 Closed

MSAC Hedge Fund Activity: Q3 2021 in Review

46 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) for Q3 2021, worth a combined $77.5M — up 8.5% from $71.4M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new MSAC positions and 3 closed out — a net gain of 2 holders — while 12 added to existing stakes and 5 trimmed.

The largest buyer was Saba Capital Management, adding an estimated $3.46M. The largest seller was J. Goldman & Co, exiting entirely with an estimated $2.89M sold.

  • 46 institutional investors held Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) as of Q3 2021, up from 44 in Q2 2021.
  • Funds reported $77.5M of Medicus Sciences Acquisition Corp. Class A Ordinary Share stock for Q3 2021, up 8.5% quarter-over-quarter.
  • 5 funds opened new Medicus Sciences Acquisition Corp. Class A Ordinary Share positions in Q3 2021 and 3 closed out, a net change of +2 holders.
  • The largest Medicus Sciences Acquisition Corp. Class A Ordinary Share buyer in Q3 2021 was Saba Capital Management, an estimated $3.46M added.
  • The largest Medicus Sciences Acquisition Corp. Class A Ordinary Share seller in Q3 2021 was J. Goldman & Co, an estimated $2.89M sold.

Based on aggregated 13F filings for Q3 2021.